Edwards Lifesciences
Global specialist in the science of heart values and hemodynamic monitoring.
Enterprise value
$42.7b
Share price
$78.21 EW
Recent deals
- Healthcare
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
Earlybird Venture Capital(exited)
TIN Capital(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 19 % | 3 % | 12 % | (9 %) | 8 % | 10 % | 10 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 28 % | 34 % | 32 % | 32 % | 30 % | 30 % | 31 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 29 % | 28 % | 23 % | 77 % | 24 % | 24 % | 25 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 17 % | 18 % | 18 % | 19 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Edwards Lifesciences
Edit
ACQUISITION by Edwards Lifesciences Oct 2012
ACQUISITION by Edwards Lifesciences Nov 2016
BUYOUT by BC Partners Jul 2021
ACQUISITION by Edwards Lifesciences Jul 2024
ACQUISITION by Edwards Lifesciences Mar 2011
ACQUISITION by Edwards Lifesciences Jul 2015
ACQUISITION by Edwards Lifesciences Jul 2024
ACQUISITION by Symetis Feb 2017
ACQUISITION by Johnson & Johnson Aug 2024